Cost-effectiveness of quadrivalent influenza vaccine in Hong Kong – A decision analysis

References

• Chan PK, Chan MC, Cheung JL, Lee N, Leung TF, Yeung ACM, Wong MCS, Ngai KLK, Nelson AS, Hui DSC. Influenza B lineage circulation and hospitalization rates in a subtropical city, hong kong, 2000-2010. Clin Infect Dis 2013; 56:677–84; PMID:23074315; http://dx.doi.org/10.1093/cid/cis885
   PubMed Web of Science ®Google Scholar
• Reed C, Meltzer MI, Finelli L, Fiore A. Public health impact of including two lineages of influenza B in a quadrivalent seasonal influenza vaccine. Vaccine 2012; 30:1993-8; PMID:22226861; http://dx.doi.org/10.1016/j.vaccine.2011.12.098
   PubMed Web of Science ®Google Scholar
• Lee BY, Bartsch SM, Willig AM. The economic value of a quadrivalent versus trivalent influenza vaccine. Vaccine 2013; 31:2477-9; PMID:23084849; http://dx.doi.org/10.1016/j.vaccine.2012.10.025
   PubMed Web of Science ®Google Scholar
• You JHS, Wong WCW, Ip M, Lee NLS, Ho SC. Cost-effectiveness analysis of influenza and pneumococcal vaccination for Hong Kong elderly in long-term care facilities. J Epidemiol Commun Health 2009; 63:906-11; PMID:19608558; http://dx.doi.org/10.1136/jech.2008.081885
   PubMed Web of Science ®Google Scholar
• Census and Statistics Department, The government of hong kong SAR. Assessed on 24 October 2013: http://www.censtatd.gov.hk/
   Google Scholar
• Chan D. Seasonal influenza vaccination coverage survey for the 2012/2013 season. Commun Dis Watch 2013; 10:74-7.
   Google Scholar
• Centers for Disease Control and Prevention. Interim within-season estimate of the effectiveness of trivalent inactivated influenza vaccine—marshfield, wisconsin, 2007–08 influenza season. Morb Mortal Wkly Rep 2008; 57:393-8; PMID:18418344
   PubMedGoogle Scholar
• Frey S, Vesikari T, Szymczakiewicz-Multanowska A, Lattanzi M, Izu A, Groth N, Holmes S. Clinical efficacy of cell culture-derived and egg-derived inactivated subunit influenza vaccines in healthy adults. Clin Infect Dis 2010; 51:997-1004; PMID:20868284; http://dx.doi.org/10.1086/656578
   PubMed Web of Science ®Google Scholar
• Monto AS, Ohmit SE, Petrie JG, Johnson E, Truscon R, Teich E, Rotthoff J, Boulton M, Victor JC. Comparative efficacy of inactivated and live attenuated influenza vaccines. N Engl J Med 2009; 361:1260-7; PMID:19776407; http://dx.doi.org/10.1056/NEJMoa0808652
   PubMed Web of Science ®Google Scholar
• Ohmit SE, Victor JC, Rotthoff JR, Teich ER, Truscon RK, Baum LL, Rangarajan B, Newton DW, Boulton ML, Monto AS. Prevention of antigenically drifted influenza by inactivated and live attenuated vaccines. N Engl J Med 2006; 355:2513-22; PMID:17167134; http://dx.doi.org/10.1056/NEJMoa061850
   PubMed Web of Science ®Google Scholar
• Ohmit SE, Victor JC, Teich ER, Truscon RK, Rotthoff JR, Newton DW, Campbell SA, Boulton ML, Monto AS. Prevention of symptomatic seasonal influenza in 2005–2006 by inactivated and live attenuated vaccines. J Infect Dis 2008; 198:312-7; PMID:18522501; http://dx.doi.org/10.1086/589885
   PubMed Web of Science ®Google Scholar
• Skowronski DM, Masaro C, Kwindt TL, Mak A, Petric LiY, Sebastian R, Chong M, Tam T, De Serres G. Estimating vaccine effectiveness against laboratory-confirmed influenza using a sentinel physician network: results from the 2005–2006 season of dual A and B vaccine mismatch in canada. Vaccine 2007; 25:2842-51; PMID:17081662; http://dx.doi.org/10.1016/j.vaccine.2006.10.002
   PubMed Web of Science ®Google Scholar
• Talbot HK, Griffin MR, Chen Q, Zhu Y, Williams JV, Edwards KM. Effectiveness of seasonal vaccine in preventing confirmed influenza-associated hospitalizations in community dwelling older adults. J Infect Dis 2011; 203:500-8; PMID:21220776; http://dx.doi.org/10.1093/infdis/jiq076
   PubMed Web of Science ®Google Scholar
• Treanor JJ, Talbot HK, Ohmit SE, Coleman LA, Thompson MG, Cheng PY, Petrie JG, Lofthus G, Meece JK, Williams JV, et al. Effectiveness of seasonal influenza vaccines in the united states during a season with circulation of all three vaccine strains. Clin Infect Dis 2012; 55:951-9; PMID:22843783; http://dx.doi.org/10.1093/cid/cis574
   PubMed Web of Science ®Google Scholar
• Lee N, Chan PK, Lui GC, Wong BC, Sin WW, Choi KW, Wong RYK, Lee ELY, Yeung ACM, Ngai KLK, et al. Complications and outcomes of pandemic 2009 influenza A (H1N1) virus infection in hospitalized adults: how do they differ from those in seasonal influenza? J Infect Dis 2011; 203:1739-47; PMID:21606532; http://dx.doi.org/10.1093/infdis/jir187
   PubMed Web of Science ®Google Scholar
• Kwong KL, Lung D, Wong SN, Que TL, Kwong NS. Influenza-related hospitalisations in children. J Paediatr Child Health 2009; 45:660-4; PMID:19845841; http://dx.doi.org/10.1111/j.1440-1754.2009.01591.x
   PubMedGoogle Scholar
• Chowell G, Miller MA, Viboud C. Seasonal influenza in the united states, france, and australia: transmission and prospects for control. Epidemiol Infect 2008; 136:852-64; PMID:17634159
   PubMed Web of Science ®Google Scholar
• Weinberg GA, Szilagyi PG. Vaccine epidemiology: efficacy, effectiveness, and the translational research roadmap. J Infect Dis 2010; 201:167-10; PMID:20402594; http://dx.doi.org/10.1086/652404
   PubMedGoogle Scholar
• Cowling BJ, Chan KH, Feng S, Chan EL, Lo JY, Peiris JS, Chiu SS. The effectiveness of influenza vaccination in preventing hospitalizations in children in hong kong, 2009-2013. Vaccine 2014; 15;32:5278-84; PMID:25092636; http://dx.doi.org/10.1016/j.vaccine.2014.07.084
   PubMedGoogle Scholar
• Sander B, Hayden FG, Gyldmark M, Garrison LPJ. Post-exposure influenza prophylaxis with oseltamivir: cost effectiveness and cost utility in families in the UK. Pharmacoeconomics 2006; 24:373-86; PMID:16605283; http://dx.doi.org/10.2165/00019053-200624040-00007
   PubMed Web of Science ®Google Scholar
• Talbird SE, Brogan AJ, Winiarski AP, Sander B. Cost-effectiveness of treating influenza-like illness with oseltamivir in the united states. Am J Health-Syst Pharm 2009; 66:469-480; PMID:19233995; http://dx.doi.org/10.2146/ajhp080296
   PubMedGoogle Scholar
• Rothberg MB, Rose DN. Vaccination versus treatment of influenza in working adults: a cost-effective analysis. Am J Med 2005; 118:68-77; PMID:15639212; http://dx.doi.org/10.1016/j.amjmed.2004.03.044
   PubMed Web of Science ®Google Scholar
• Mauskopf JA, Cates SC, Griffin AD, Neighbors DM, Lamb SC, Rutherford C. Cost effectiveness of zanamivir for the treatment of influenza in a high risk population in australia. Pharmacoeconomics 2000; 17:11-620; PMID:10977398; http://dx.doi.org/10.2165/00019053-200017060-00007
   PubMedGoogle Scholar
• Luce BR, Nichol KL, Belshe RB, Frick KD, Li SX, Boscoe A, Rousculp MD, Mahadevia PJ. Cost-effectiveness of live attenuated influenza vaccine versus inactivated influenza vaccine among children ages 24–59 months in the united states. Vaccine 2008; 26:2841-8; PMID:18462851; http://dx.doi.org/10.1016/j.vaccine.2008.03.046
   PubMedGoogle Scholar
• Tengs TO, Wallace A. One thousand health-related quality-of-life estimates. Med Care 2000; 38:583-637; PMID:10843310; http://dx.doi.org/10.1097/00005650-200006000-00004
   PubMed Web of Science ®Google Scholar
• Sackett DL, Torrance GW. The utility of different health states as perceived by the general public. J Chronic Dis 1978; 31:697-704; PMID:730825; http://dx.doi.org/10.1016/0021-9681(78)90072-3
   PubMedGoogle Scholar
• Petrie JG, Ohmit SE, Hohnson E, Cross RT, Monto AS. Efficacy studies of influenza vaccines: effect of end points used and characteristics of vaccine failures. J Infect Dis 2011; 203:1309-15; PMID:21378375; http://dx.doi.org/10.1093/infdis/jir015
   PubMed Web of Science ®Google Scholar
• Chiu SS, Chan KH, So LY, Chen R, Chan ELY, Peiris JSM. The population based socioeconomic burden of pediatric influenza-associated hospitalization in Hong Kong. Vaccine 2012; 30:1895-1900; PMID:22222872; http://dx.doi.org/10.1016/j.vaccine.2011.12.027
   PubMedGoogle Scholar
• Gold MR, Franks P, McCoy KI, Fryback DG. Toward consistency in cost-utility analyses: using national measures to create condition-specific values. Medical Care 1998; 36:778-92; PMID:9630120; http://dx.doi.org/10.1097/00005650-199806000-00002
   PubMed Web of Science ®Google Scholar
• Fees and Charges, Hospital Authority, Hong Kong. Assessed on 7 October 2013: http://www.ha.org.hk
   Google Scholar
• Cost-effectiveness thresholds. World health organization. Assessed on 3 December 2013: http://www.who.int/choice/costs/CER_thresholds/en/index.html
   Google Scholar